These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 10091585)

  • 1. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.
    van der Neut Kolfschoten M; Dirven RJ; Vos HL; Tans G; Rosing J; Bertina RM
    J Biol Chem; 2004 Feb; 279(8):6567-75. PubMed ID: 14660667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
    Aparicio C; Dahlbäck B
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
    Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
    Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
    Villoutreix BO; Dahlbäck B
    Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for blood coagulation factor Xa and protein S involving residues 493-506 in factor Va.
    Heeb MJ; Kojima Y; Hackeng TM; Griffin JH
    Protein Sci; 1996 Sep; 5(9):1883-9. PubMed ID: 8880912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a factor Xa binding site on factor Va near the Arg-506 activated protein C cleavage site.
    Gale AJ; Yegneswaran S; Xu X; Pellequer JL; Griffin JH
    J Biol Chem; 2007 Jul; 282(30):21848-55. PubMed ID: 17553804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va.
    Norstrøm EA; Tran S; Steen M; Dahlbäck B
    J Biol Chem; 2006 Oct; 281(42):31486-94. PubMed ID: 16935856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C.
    Gale AJ; Xu X; Pellequer JL; Getzoff ED; Griffin JH
    Protein Sci; 2002 Sep; 11(9):2091-101. PubMed ID: 12192065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va.
    Tran S; Norstrøm E; Dahlbäck B
    J Biol Chem; 2008 Mar; 283(11):6648-55. PubMed ID: 18198180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.
    Yegneswaran S; Nguyen PM; Gale AJ; Griffin JH
    Thromb Haemost; 2009 Jan; 101(1):55-61. PubMed ID: 19132189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol enhances phospholipid-dependent activated protein C anticoagulant activity.
    Pecheniuk NM; Deguchi H; Griffin JH
    J Thromb Haemost; 2005 Feb; 3(2):340-5. PubMed ID: 15670041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505.
    Dirven RJ; Vos HL; Bertina RM
    Thromb Res; 2010 May; 125(5):444-50. PubMed ID: 20051284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
    Silveira JR; Kalafatis M; Tracy PB
    Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor Va residues 311-325 represent an activated protein C binding region.
    Yegneswaran S; Kojima Y; Nguyen PM; Gale AJ; Heeb MJ; Griffin JH
    J Biol Chem; 2007 Sep; 282(39):28353-28361. PubMed ID: 17646160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.
    Majumder R; Quinn-Allen MA; Kane WH; Lentz BR
    Blood; 2008 Oct; 112(7):2795-802. PubMed ID: 18587009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
    Gierula M; Salles-Crawley II; Santamaria S; Teraz-Orosz A; Crawley JTB; Lane DA; Ahnström J
    J Thromb Haemost; 2019 Dec; 17(12):2056-2068. PubMed ID: 31364267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO; Kalafatis M; Mann KG
    Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.